期刊文献+

地特胰岛素联合瑞格列奈对2型糖尿病患者血糖波动、氧化应激的影响 被引量:23

Effect of insulin detemir combined with repaglinide on blood glucose fluctuation and oxidative stress in type 2 diabetic patients
暂未订购
导出
摘要 目的观察地特胰岛素联合应用瑞格列奈对2型糖尿病患者血糖波动、氧化应激水平的影响。方法 2型糖尿病患者60例随机分为2组,每组30例。联合组给予地特胰岛素联合瑞格列奈治疗,单药组单纯给予瑞格列奈治疗,同时选取性别、年龄、体质量指数(BMI)等一般情况相匹配的健康体检者26例作为健康对照组,观察治疗前后糖化血红蛋白(HbA_(1c))、空腹血糖(FPG)、餐后2 h血糖(2 hPG)、平均血糖波动幅度(MAGE)和日间血糖平均绝对值(MODD)、血丙二醛(MDA)和超氧化物歧化酶(SOD)的变化。结果与健康对照组比较,治疗前单药组、联合组FPG、2 hPG、HbA)(1c)、MDA均升高,SOD均降低(P<0.01);治疗后2组FPG、2 hPG、HbA_(1c)、MDA、MAGE、MODD均较治疗前降低,SOD较治疗前升高(P<0.05),且联合组MDA、MAGE、MODD、HbA_(1c)下降及SOD升高较单药组更明显(P<0.05)。结论地特胰岛素联合瑞格列奈治疗2型糖尿病,可减少血糖波动,减轻2型糖尿病患者体内的氧化应激水平。 Objective To investigate the levels of blood glucose fluctuation and oxidative stress in type 2 diabetic patients treated with insulin detemir in combination with repaglinide. Methods sixty diabetic patients were randomly assigned to receive insulin detemir and repaglinide (combine group, n = 30) or repaglinide (treatment group, n = 30). Meanwhile, another 26 healthy subjects were selected as normal control (control group), which matched the included patients in gender, age and body mass indexes (BMI). The relevant indexes were observed and compared before and after the treatment, including glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG) ,2h postprandial blood glucose (2h PG), mean amplitude glycemic excursions ( MAGE ), mean of daily differences ( MODD ), malondialdehyde ( MDA), superoxide dismutase (SOD). Results The levels of FPG,2hPG, HbAlc, MDA were remarkably higher in both combine group and treatment group than in control group ( P 〈 0.01 ), the levels of SOD were lower. After the treatment, the levels PPG,2hPG, HbA1c, MDA, MAGE, MODD in these two groups were significantly lower than before ( P 〈 0.05 ) ; and the levels of SOD were markedly higher. The levels of MDA, MAGE, MODD, HbAlo were significantly lower in combine group than treatment group, and the levels of SOD were markedly higher ( P 〈 0. 05). Conclusion Insulin detemir combined with repaglinide for treating type 2 diabetic patients, could decrease blood glucose fluctuation, and reduce oxidative stress in type :2 diabetic patients.
出处 《疑难病杂志》 CAS 2013年第7期502-504,共3页 Chinese Journal of Difficult and Complicated Cases
基金 河北省科学技术研究与发展计划项目(No.122777152)
关键词 糖尿病 2型 氧化应激 血糖波动 地特胰岛素 瑞格列奈 Diabetes mellitus, type 2 Oxidative stress Blood glucose fluctuation Insulin detemir Repaglinide
  • 相关文献

参考文献16

二级参考文献105

共引文献111

同被引文献150

  • 1周巍巍,黄亚薇,李悦平.门冬酸胰岛素30注射液及精蛋白生物合成人胰岛素(预混30R)治疗2型糖尿病疗效观察[J].当代医学,2008,14(14). 被引量:3
  • 2季保玉,张志敏.瑞格列奈治疗2型糖尿病的疗效观察[J].安徽医学,2013,34(10):1535-1536. 被引量:4
  • 3沈海林,沈纪芳,秦颂兵,芮春朵,唐健,许昌韶,周菊英,刘国强.大鼠全脑照射后早期放射性脑损伤的磁共振波谱与病理对照研究[J].临床放射学杂志,2005,24(9):818-823. 被引量:23
  • 4Sandovici, Ionel/I; Hammerle, Constanze M/CM; Ozanne, Susan E/SE;Developmental and environmental epigenetic programming of the endocrine pancreas: con- sequences for type 2 diabetes [J]. Cellular and molecular life sciences : CMLS.2013 May;70(9): 1575-95.
  • 5Yamagishi S,Matsui T,Ueda S,et al.Clinical utility of acarbose,an alpha-glucosidase inhibitor in cardiometabolic disorders[J].Curr Drug Metab,2009,10(2):159-163.
  • 6Shankar A,Li J.Positive association between highsensitivity C-reactive protein level and diabetes mellitus among US non-Hispanic black adults[J].Exp Clin Endocrinol Diabetes,2008,116(8):455-460.
  • 7Aroda VR,De Young MB.Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2diabetes[J].Postgrad Med,2011,123(5):228-238.
  • 8Karagianni P,Polyzos SA,Kartali N,et al.Comparative efficacy of exenatide versus insulin glargine on glycemic control in type 2diabetes mellitus patients inadequately treated with metformin monotherapy[J].Adv Med SCI,2013,58(1):38-43.
  • 9王文霞,贾伟平,包玉倩,李青,陆惠娟,项坤三.肾小球滤过率评价糖尿病患者肾功能的意义及方法学比较[J].中华医学杂志,2007,87(48):3385-3388. 被引量:28
  • 10Williams-Herman D,XU L,Teng R,et al.Effect of initial com- bination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes[J].Diab Obes Metab, 2012,14(1):67-76.

引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部